Blocking interleukin-11 may shift genome repair toward error-prone end joining

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Can blocking an inflammatory signal fail to slow human aging because it also weakens repair or infection defenses?

The engine's own statement of the hypothesis, in full.

HERETICAL, conditional: In a prospectively specified population of cycling epithelial progenitors from aging humans, endogenous IL-11 signaling may preserve DNA-break repair fidelity. Blocking IL-11 could shift repair toward polymerase-theta-mediated end joining, increasing newly generated deletions and rearrangements in surviving descendants despite reduced inflammatory injury, adequate early wound closure and mature epithelial function, and initially preserved pathogen clearance. Each concurrent outcome requires separate demonstration. The proposed fidelity defect concerns repair of comparable damage substrates within tracked lineages; more errors caused solely by changed lesion production, location or complexity would not establish it. Persistent genomic damage could later increase malignant or organ-failure transitions within SPV_3 and offset an independently demonstrated beneficial effect. Persistence, clinical consequence and sufficient magnitude for cancellation remain additional conditional links.

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

• Rival 01 of 04

  Disrupted interleukin-11 feedback may uncouple epithelial and stromal repair
  What would separate them

  Disrupted interleukin-11 feedback may uncouple epithelial and stromal repair predicts: First identify a native responsive older-human lung epithelial–stromal sender–receiver pair. Independently perturb sender repair state across independently varied receiver starting states while controlling initial injury, matrix, nutrients and nonspecific support. Measure whether endogenous IL-11 output changes with sender state and whether selective sender IL-11 loss and receiver IL11RA loss interrupt the attributable response, with appropriate perturbation-alone and restoration controls. Monitor other secretions, nutrient changes, matrix changes and material transport. Then randomize correct alignment versus mismatch between actual partner state and delivered IL-11-dependent signal. Compare contingent signals with yoked signals from independently assigned, appropriately matched partners, shuffled signals and state-independent schedules. Balance waveform amplitude, duration, integrated exposure, pulse statistics and relevant delay distributions where feasible, while retaining state–signal alignment as the changed variable. Measure realized receptor activation and adaptation without forcing complete mediator histories to equality. The focal prediction is that mismatch impairs complementary mature differentiation and barrier recovery and correct alignment reverses this penalty while isolated competence and lower mean inflammatory signaling remain separately verified. A favorable separation additionally requires maintained reduction in actual inflammatory injury during rescue, with cell-specific exposure, peaks and duration assessed; a lower average can conceal damaging local pulses. Equivalent recovery with an appropriately chosen state-independent schedule after receiver readiness, shared injury history and support are addressed favors the alternative that actual partner state adds no necessary guidance. Unmatched replay superiority, equal integrated ligand and pulse-versus-tonic superiority are insufficient. Demonstrated endogenous feedback supports the biological coupling claim but does not establish novelty beyond reciprocal paracrine support or validate the consensus equation. For the model, calibrate coordinates and parameters independently and predict held-out changes in sender state, communication edges, delays and mature functional recovery; compare these predictions with receiver-only exposure/support models.

• Rival 02 of 04

  Interleukin-11 may reflect injury while exerting little control over human aging
  What would separate them

  Interleukin-11 may reflect injury while exerting little control over human aging predicts: Test limited benefit and limited harm separately after a prospectively justified transient interval. At demonstrated tissue exposure, validated damage and functional trajectories should lie within prespecified consequential equivalence bounds, while repair, pathogen control and adverse channels independently meet their own bounds. Aggregate nonsignificance supports neither neutrality nor cancellation. If a candidate cost appears, use randomized control C, blockade B, rescue alone R and blockade-plus-rescue BR arms. Verify comparable blockade exposure and target engagement in B and BR, demonstrate adverse-mediator removal, and measure the rescue's independent effects. For Y oriented so that higher is better, estimate Δ0=Y_B−Y_C, ΔR=Y_BR−Y_R and interaction I=ΔR−Δ0. A favorable BR−B contrast does not identify blockade benefit; a favorable ΔR or interaction does not alone identify cancellation. The prediction that no consequential blockade benefit emerges under rescue is conditional on rescue preserving the relevant biological context, beneficial pathways and effect modifiers apart from removing a demonstrated blockade-induced harmful component. Test that preservation using direct mediator, cell-state, exposure and beneficial-channel measurements; rescue specificity by itself does not establish it. If rescue creates a new permissive state or interaction, benefit under rescue remains compatible with neutrality in the original setting. To support cancellation, demonstrate beneficial and harmful effects of blockade before rescue at the same exposure and relevant duration, then show selective removal of the harmful component while the beneficial route remains operative. Even with a factorial interaction, alternative synergy requires consideration. Failure to uncover benefit remains inconclusive when rescue is incomplete, context changes, exposure differs, precision is inadequate or follow-up is too short. Marker behavior, disease-specific amplification and redundancy require additional causal tests and are not identified by equivalence alone.

• Rival 03 of 04

  Blocking interleukin-11 may free shared receptors to sustain harmful competing signals
  What would separate them

  Blocking interleukin-11 may free shared receptors to sustain harmful competing signals predicts: In a characterized older-human epithelial population under fixed defined ligands, an occupancy-releasing blocker should produce a quantitatively compatible loss of gp130 from IL-11 complexes and gain in specified competing complexes within the same accessible pool. Resolve individual cells and relevant membrane compartments with sufficient temporal resolution to establish exchange compatibility before the competing signal and functional cost. Reciprocal population or whole-cell averages from different subpopulations or disconnected compartments are insufficient. Use convergent minimally perturbing complex and localization measurements and, where validated, tracking of component movement or a pool-selective perturbation to test access and exchange. Account for free, other-bound, incoming, internalized and recycled components rather than assume direct one-for-one transfer. Compare blocker modalities at comparable IL-11 inhibition; occupancy-retaining inhibition need not redistribute gp130. Independently demonstrate a limiting range where additional accessible surface gp130 increases competing-complex assembly and a nonlimiting range where further increases do not materially increase assembly, with adequate precision and unsaturated detection. Independently verify that downstream and functional readouts retain responsive range. Quantify receptor abundances, ratios, localization, baseline complexes and trafficking across the manipulation. Only the conjunction of same-pool allocation, validated limitation and its relief, responsive readouts and functional mediation supports competition. Controlled occupancy restoration should reverse allocation, subject to controls for its effects on signaling and trafficking. Competing-receptor interruption should remove the attributable cost while IL-11 suppression persists, with interruption-alone controls. Rescue or attenuation at high gp130 alone does not distinguish allocation from feedback, saturation or trafficking. Follow the acute step into sustained harmful differentiation or function and post-transient deterioration; neutral, beneficial or transient allocation does not confirm the harmful extension.

• Rival 04 of 04

  Interleukin-11 blockade may change displayed self-peptides and trigger immune injury
  What would separate them

  Interleukin-11 blockade may change displayed self-peptides and trigger immune injury predicts: First establish epithelial IL-11 responsiveness and a reproducible change in endogenous displayed self-peptide species under orthogonal epithelial IL-11 perturbations. Identify peptide sequence, relevant modifications and presenting HLA molecule. Compare baseline and treated samples with quantitative recovery controls, targeted baseline measurements and explicit detection limits. Baseline non-detection cannot establish absolute absence. Constrain baseline abundance and compare it with independently characterized recognition over physiological display ranges, testing whether increased abundance of an unchanged species can explain recognition. If that account remains plausible, report identity change as unresolved; do not count new detection as confirmation or reject broader antigen-specific harm. At comparable cell composition and total presentation, the full chain predicts altered proteasomal processing before the repertoire change, recognition by a baseline memory population with independently demonstrated cognate specificity, and then selective killing. Measure source proteins, direct cleavage products, transport/loading, HLA composition, turnover and cell state. Selective processing intervention should prevent the identity change and attributable injury while preserving epithelial fitness; physiological downstream reconstitution should restore the specified peptide–HLA complex and recognition. Broad proteasome inhibition is insufficient. Separately remove and restore the implicated peptide–HLA–T-cell-receptor interaction at endogenous-range display, preserving source-protein function and IL-11 blockade. Include epithelial-only, T-cell-only, coculture, perturbation-alone and pretreatment/washout controls with residual drug and pathway-state measurements. Demonstrate baseline memory phenotype, specificity, tissue access and response under prospectively defined physiological activation support; strong artificial stimulation cannot establish the in-tissue conjunction. Measure preserved intrinsic repair, adequate laboratory pathogen killing and reduced soluble inflammatory markers separately. Follow repeated killing, replacement, immune restraint and barrier function before claiming persistent injury. Identity change without processing mediation leaves the proteasomal link open; antigen-specific killing without an identified switch supports only a partial or alternative route. Injury independent of the specified recognition pair favors stress, bystander activation or generalized susceptibility.

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.